063 – Combination Products Regulatory, Going Wide, and Patient Impact with Niedre Heckman

Podcast episode cover

December 14, 2022

063 – Combination Products Regulatory, Going Wide, and Patient Impact with Niedre Heckman

Share

Show Notes

On this episode, I was joined by Niedre Heckman, MPH, PhD, FRAPS, Director of Regulatory Affairs Strategy, CMC, Medical Devices, Combination Products at Takeda.

Niedre discusses:

Key Topics

  • Challenges with global regulatory strategies for combination products
  • Impact of regulatory strategies on patients and product adoption
  • Becoming an FRAPS, and building wide expertise in QA & RA
  • Being a great teammate/colleague

Niedre Heckman, PhD, MPH, FRAPS is the Director of Regulatory Affairs Strategy, CMC, Medical Devices, Combination Products at Takeda. She's a fellow of Regulatory Affairs Professionals Society (RAPS) (FRAPS), and holds an MPH and PhD in Public Health. Niedre has worked at Takeda, Baxter International Inc., Shire, Baxalta, 3M, and GSK. Niedre has a wide career in Regulatory Affairs, Quality, and Research with focuses in many modalities of medical devices, pharmaceuticals and combination products. Niedre couples her background in RA & QA with her expertise in public health to bring a uniquely patient centric point of view.

Join Our news Letter

By signing up, you agree to receive email from this podcast.

Recent Episodes

July 22, 2026

247 – Why Everyone in Pharma and MedTech Should Work in Quality

July 15, 2026

246 – The 3 Ways to Structure a Quality Management System (Centralized vs. Federated vs. Decentralized)

July 8, 2026

245 – Reducing a 14-Step Emergency Injection to a Two-Step Auto-Injector

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.